MedTrace Logo

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)

NCT04768998 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6550

Last updated 2021-02-24

No results posted yet for this study

Summary

The intersectoral platform is part of the National Pandemic Cohort Network (NAPKON) and will be used to provide a comprehensive and harmonized collection of data and biomaterial for researchers from national consortia, pharmaceutical companies and for participation in international research collaborations for the purpose of studying COVID-19 disease and future pandemics.

Conditions

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Interventions

OTHER

Observational of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings

Observatory Cohorts focusing (I) on subjects after SARS-CoV-2 infection that are recruited from the general population (POP), and on subjects with acute SARS-CoV-2 infections recruited (II) in university hospital high-care settings or (III) general health care.

Sponsors & Collaborators

  • Nationwide Network of University Medicine (NUM) on Covid-19

    collaborator UNKNOWN

  • Goethe University

    lead OTHER

Principal Investigators

  • Jörg J Vehreschild, Prof. · Johann Wolfgang Goethe-Universität Frankfurt am Main

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-04
Primary Completion
2021-03-31
Completion
2023-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04768998 on ClinicalTrials.gov